Weber, Wilfried 1974-
Weber, Wilfried, 19..-....
Weber, Wilfried, Prof. Dr.
Wilfried Weber researcher
VIAF ID: 225118715 ( Personal )
Permalink: http://viaf.org/viaf/225118715
Preferred Forms
-
- 100 1 _ ‡a Weber, Wilfried ‡d 1974-
- 100 1 _ ‡a Weber, Wilfried, ‡c Prof. Dr.
- 100 1 _ ‡a Weber, Wilfried, ‡d 19..-....
- 100 0 _ ‡a Wilfried Weber ‡c researcher
4xx's: Alternate Name Forms (2)
5xx's: Related Names (4)
- 510 2 _ ‡a Albert-Ludwigs-Universität Freiburg ‡b Centre for Biological Signalling Studies ‡4 affi ‡4 https://d-nb.info/standards/elementset/gnd#affiliation ‡e Affiliation
- 510 2 _ ‡a Albert-Ludwigs-Universität Freiburg ‡b Institut für Biologie II ‡4 affi ‡4 https://d-nb.info/standards/elementset/gnd#affiliation ‡e Affiliation
- 551 _ _ ‡a Freiburg im Breisgau ‡4 ortw ‡4 https://d-nb.info/standards/elementset/gnd#placeOfActivity
- 510 2 _ ‡a Leibniz-Institut für Neue Materialien ‡4 affi ‡4 https://d-nb.info/standards/elementset/gnd#affiliation ‡e Affiliation
Works
Title | Sources |
---|---|
Benchmarking of Cph1 mutants and DrBphP for light‐responsive phytochrome‐based hydrogels with reversibly adjustable mechanical properties | |
Biofunctionalized materials featuring feedforward and feedback circuits exemplified by the detection of botulinum toxin A | |
Breast cancer stem cell–derived tumors escape from [gamma][delta] T-cell immunosurveillance in vivo by modulating [gamma][delta] T-cell ligands | |
Cell and tissue reaction engineering | |
Characterization of the synthetic biology-inspired implementation of a materials-based positive feedback loop | |
A chemical switch for controlling viral infectivity | |
Ciblage de la réponse aux dommages à l'ADN avec des nanobodies | |
Clinical on-site monitoring of ß-lactam antibiotics for a personalized antibiotherapy | |
Creation of a light-induced intein splicing tool for protein reconstitution | |
Cross-TCR antagonism revealed by optogenetically tuning the half-life of the TCR ligand binding | |
Data-driven modeling of intracellular auxin fluxes indicates a dominant role of the ER in controlling nuclear auxin uptake | |
Design of a biohybrid materials circuit with binary decoder functionality | |
Design of a human rhinovirus-14 3C protease-inducible caspase-3 | |
Designed miniaturization of microfluidic biosensor platforms using the stop-flow technique | |
Designing electrochemical microfluidic multiplexed biosensors for on-site applications | |
Development of genetically-encoded biosensors with microfluidic large scale integration technology | |
Dual-controlled optogenetic system for the rapid down-regulation of protein levels in mammalian cells | |
Dynamic fine-tuning of CAR-T cell therapy | |
Flow-based regenerable chemiluminescence receptor assay for the detection of tetracyclines | |
food additive vanillic acid controls transgene expression in mammalian cells and mice | |
Human atrial fibroblast adaptation to heterogeneities in substrate stiffness | |
Light-controlled affinity purification of protein complexes exemplified by the resting ZAP70 interactome | |
Multichromatic control of signaling pathways in mammalian cells | |
Multiplexed biosensor for point-of-care COVID-19 monitoring: CRISPR-powered unamplified RNA diagnostics and protein-based therapeutic drug management | |
Multiplexed protein caging: orthogonal and on-command release of angiogenesis-promoting factors | |
NERNST: a genetically-encoded ratiometric non-destructive sensing tool to estimate NADP(H) redox status in bacterial, plant and animal systems | |
Novel lectin-based chimeric antigen receptors target Gb3-positive tumour cells | |
Opto-APC: Engineering of cells that display phytochrome B on their surface for optogenetic studies of cell-cell interactions | |
Optogenetic approaches for the spatiotemporal control of signal transduction pathways | |
Optogenetic control of integrin-matrix interaction | |
Optogenetic control shows that kinetic proofreading regulates the activity of the T cell receptor | |
Optogenetically controlled RAF to characterize BRAF and CRAF protein kinase inhibitors | |
Overcoming physiological barriers to nanoparticle delivery - are we there yet? | |
A Photoreceptor-Based Hydrogel with Red Light-Responsive Reversible Sol-Gel Transition as Transient Cellular Matrix | |
Real-time monitoring of cell surface protein arrival with split luciferases | |
A red/far-red light-responsive bi-stable toggle switch to control gene expression in mammalian cells | |
A red light-controlled synthetic gene expression switch for plant systems | |
Reversible shielding and immobilization of liposomes and viral vectors by tailored antibody‐ligand interactions | |
Rotlicht-gesteuerter viraler Gentransfer mit Einzelzellauflösung | |
Single molecule imaging of the initial steps of EGFR activation in Mammalian cells | |
Smart hydrogels for the augmentation of bone regeneration by endogenous mesenchymal progenitor cell recruitment | |
Spatially defined gene delivery into native cells with the red light‐controlled OptoAAV technology | |
Stabilization of membrane topologies by proteinaceous remorin scaffolds | |
StrigoQuant: a genetically encoded biosensor for quantifying strigolactone activity and specificity | |
Synthetic biology: emerging concepts to design and advance adeno‐associated viral vectors for gene therapy | |
Synthetic Gene Networks : Methods and Protocols | |
A synthetic mammalian network to compute population borders based on engineered reciprocal cell-cell communication | |
Systematic reconstruction of binding and stability landscapes of the fluorogenic aptamer spinach | |
Targeting DNA damage response with nanobodies. | |
A two-step approach for the design and generation of nanobodies |